Evidence map›Paper›PMID 39542396›Full record

ArticlePractical radiation oncology

Best Practice Guidelines for Use of Reference Points in Radiation Oncology Information Systems to Aggregate Longitudinal Dosimetric Data.

Alon Witztum, Younes Jourani, Emily Y Hirata, Todd McNutt, Tony Tadic, Kristy K Brock, David S Hong, Michelle E Howard, Andra V Krauze, Peter A Balter and 5 more

Abstract read
In one paragraph

Article in Practical radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alon WitztumDepartment of Radiation Oncology, University of California, San Francisco, California. Electronic address: alon.witztum@ucsf.edu.
Younes JouraniDepartment of Medical Physics, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium.
Emily Y HirataDepartment of Radiation Oncology, University of California, San Francisco, California.
Todd McNuttDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
Tony TadicRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Kristy K BrockDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
David S HongDepartment of Radiation Oncology, University of California, Irvine, California.
Michelle E HowardDepartment of Radiation Oncology, University of Iowa, Iowa City, Iowa.
Andra V KrauzeNational Cancer Institute, NIH, Radiation Oncology Branch, Center for Cancer Research, Bethesda, Maryland.
Peter A BalterDepartment of Radiation Oncology, University of California, Irvine, California.
Abigail L StockhamDepartment of Radiation Oncology, Mayo Clinic, Rochester, New York.
Elizabeth L CovingtonDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Ying XiaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Richard PoppleMedical Physics Division, University of Alabama at Birmingham, Birmingham, Alabama.
Charles S MayoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TITT, UWE · 2021 to 2025
$14.0M
CTSA K12 Program at The University of IowaK12TR004382 · NCATS · UNIVERSITY OF IOWA · PI ALEXANDER G BASSUK, Polly J Ferguson · 2023 to 2026
$3.0M
Optimization and Evaluation of Anatomical Models of Liver Radiation ResponseR01CA221971 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BROCK, KRISTY · 2018 to 2022
$1.8M
Intramural NIH HHS Z99 CA999999NCATS NIH HHS K12 TR004382NCI NIH HHS P01 CA261669NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA221971
6 · The paper itself

Abstract

purposeTracking patient doses in radiation oncology is challenging because of disparate electronic systems from various vendors. Treatment planning systems (TPS), radiation oncology information systems (ROIS), and electronic health records (EHR) lack uniformity, complicating dose tracking and reporting. To address this, we examined practices in multiple radiation oncology settings and proposed guidelines for current systems. METHODS AND MATERIALS: A survey was conducted among members of various professional groups to understand dose reporting practices in TPS, ROIS, and EHR systems. The aim was to identify consistent components and develop guidelines.

resultsWe identified 6 treatment scenarios where current ROIS defaults fail to accurately represent dose totals. A standardized approach involving 3 reference point types - primary treatment plan reference, dose check, and prescription tracking - was proposed to address these scenarios. Standardizing naming conventions for reference points was also recommended for easier integration with EHRs. The approach requires minimal modifications to existing systems and facilitates easier data transfer and display in EHRs.

conclusionsStandardizing reference points in commercial TPS and ROIS can bridge infrastructure gaps and improve dose tracking in complex clinical scenarios. This standardization, aligned with the American Association of Physicists in Medicine's Task Group (TG) 263, paves the way for continual development of automated, standardized, interoperable tools, enhancing the ease of sharing reference point information.

Indexed as

Practice Guidelines as TopicRadiation OncologyRadiometryRadiotherapy Planning, Computer-AssistedElectronic Health RecordsHumansRadiotherapy Dosage

Identifiers

PMID39542396
PMCPMC12064360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.